Paracelsus Medical University Salzburg - Oncology
About Paracelsus Medical University Salzburg - Oncology
The Paracelsus Medical University is a private university located in Salzburg municipality, Austria and Nuremberg, Germany.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Austrian Breast & Colorectal Cancer Study Group
11
Arbeitsgemeinschaft medikamentoese Tumortherapie
4
Medical University Innsbruck
2
Medical University of Vienna
2
Merck KGaA, Darmstadt, Germany
2
Cornerstone Pharmaceuticals
1
Incyte Corporation
1
Medical University of Graz
1
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
1
Paracelsus Medical University
1
Pulsar Vascular
1
Clinical Trials at Paracelsus Medical University Salzburg - Oncology
During the past decade, Paracelsus Medical University Salzburg - Oncology conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 3 clinical trials were completed, i.e. on
average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane
2000-09-01
2009-03-01
Completed
98
Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
1999-06-01
2018-06-26
Completed
1,803
Preoperative Chemoradiation With Capecitabine and Cetuximab
2005-10-01
2011-11-01
Completed
31
Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma
2004-10-01
2013-12-01
Completed
60
Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C
1990-10-01
Completed
598
Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B
1993-11-01
Completed
636
Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer
2005-02-01
2011-11-01
Completed
536
SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme
2007-10-01
2011-01-01
Unknown status
70
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Paracelsus Medical University Salzburg - Oncology" #1 sponsor was "Austrian Breast & Colorectal Cancer Study Group" with 11 trials, followed by "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 4 trials
sponsored, "Medical University Innsbruck" with 2 trials sponsored, "Medical University of Vienna" with 2 trials sponsored and "Merck KGaA, Darmstadt, Germany"
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Paracelsus Medical University Salzburg - Oncology"
#1 collaborator was "Hoffmann-La Roche" with 6 trials as a collaborator, "Amgen" with 3 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Paracelsus Medical University" with 2 trials as a collaborator and "Assign Data Management and Biostatistics GmbH" with 1 trials as a collaborator. Other collaborators include 30 different institutions and companies that were
collaborators in the rest 40 trials.
Clinical Trials Conditions at Paracelsus Medical University Salzburg - Oncology
According to Clinical.Site data, the most researched conditions in "Paracelsus Medical University Salzburg - Oncology" are
"Breast Cancer" (4 trials), "Multiple Sclerosis" (3 trials), "Rectal Cancer" (3 trials), "Brain Aneurysm" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Paracelsus Medical University Salzburg - Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Paracelsus Medical University Salzburg - Oncology
Most popular intervention types in "Paracelsus Medical University Salzburg - Oncology" are "Drug" (18 trials), "Device" (3 trials), "Procedure" (2 trials), "Diagnostic Test" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Capecitabine" (3 trials), "Mavenclad®" (3 trials), "Oxaliplatin" (2 trials), "5-fluorouracil, levamisol, interferon" (1 trials) and "CPI-613 + High Dose Cytarabine and Mitoxantrone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Paracelsus Medical University Salzburg - Oncology
The vast majority of trials in "Paracelsus Medical University Salzburg - Oncology" are
24 trials for "All" genders and 5 trials for "Female" genders.
Clinical Trials Status at Paracelsus Medical University Salzburg - Oncology
Currently, there are NaN active trials in "Paracelsus Medical University Salzburg - Oncology".
undefined are not yet recruiting,
5 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 16 completed trials in Paracelsus Medical University Salzburg - Oncology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Paracelsus Medical University Salzburg - Oncology, 0 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 4 trials that are defined as “Not Applicable".